Search

Author/Creator Molina-Vila, M.A.

2. 3120 Analysis of gene expression in the re-replication pathway and selective blockade with checkpoint inhibitors as a therapeutic option in NSCLC. (September 2015)

Authors:
Morales-Espinosa, D.; Molina-Vila, M.A.; Giménez-Capitán, A.; García-Román, S.; Bertrán-Alamillo, J.; Méndez-Romero, P.; Ramírez-Serrano, J.L.; Viteri, S.; Karachaliou, N.; Rosell, R.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC. (February 2022)

Authors:
Rodríguez-Abreu, D.; Cobo, M.; García-Román, S.; Viteri-Ramírez, S.; Jordana-Ariza, N.; García-Peláez, B.; Reguart, N.; Aguilar, A.; Codony-Servat, J.; Drozdowskyj, A.; Molina-Vila, M.A.; d'Hondt, E.; Rosell, R.
Journal:
Lung cancer
Issue:
Volume 164(2022)
Page Start:
8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗